Drug Profile
Metronidazole sustained release - Beijing CoSci Med Tech
Latest Information Update: 25 Dec 2021
Price :
$50
*
At a glance
- Originator Beijing CoSci Med-Tech
- Class Antibacterials; Antiprotozoals; Nitroimidazoles; Radiosensitisers; Skin disorder therapies; Small molecules
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Bacterial vaginosis
Most Recent Events
- 27 Jul 2016 Chemical structure information added
- 26 Jul 2016 Investigation in Bacterial vaginosis in China (PO)